Fisher & Paykel Healthcare's stock surged 8.54% intraday on Tuesday, significantly outperforming the broader market.
The sharp rise followed the company's release of its fiscal 2026 earnings report, which showed underlying earnings per share of NZ$0.793, a substantial increase from NZ$0.639 a year earlier, indicating strong financial performance and growth.
The health technology sector was a notable gainer on the exchange during the session, with Fisher & Paykel Healthcare leading the advance.